346 related articles for article (PubMed ID: 28028618)
21. Isolation and Characterization of a Novel
Morozova V; Babkin I; Kozlova Y; Baykov I; Bokovaya O; Tikunov A; Ushakova T; Bardasheva A; Ryabchikova E; Zelentsova E; Tikunova N
Viruses; 2019 Dec; 11(12):. PubMed ID: 31810319
[No Abstract] [Full Text] [Related]
22. Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional Characterization.
Hsieh PF; Lin HH; Lin TL; Chen YY; Wang JT
Sci Rep; 2017 Jul; 7(1):4624. PubMed ID: 28676686
[TBL] [Abstract][Full Text] [Related]
23. Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.
Brown TL; Petrovski S; Hoyle D; Chan HT; Lock P; Tucci J
PLoS One; 2017; 12(8):e0183510. PubMed ID: 28817689
[TBL] [Abstract][Full Text] [Related]
24. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.
Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT
J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Three Toxic Proteins of
Spruit CM; Wicklund A; Wan X; Skurnik M; Pajunen MI
Viruses; 2020 May; 12(5):. PubMed ID: 32429141
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterisation of KP34--a novel φKMV-like bacteriophage for Klebsiella pneumoniae.
Drulis-Kawa Z; Mackiewicz P; Kęsik-Szeloch A; Maciaszczyk-Dziubinska E; Weber-Dąbrowska B; Dorotkiewicz-Jach A; Augustyniak D; Majkowska-Skrobek G; Bocer T; Empel J; Kropinski AM
Appl Microbiol Biotechnol; 2011 May; 90(4):1333-45. PubMed ID: 21327407
[TBL] [Abstract][Full Text] [Related]
27. Characterization and genome analysis of novel Klebsiella phage BUCT556A with lytic activity against carbapenemase-producing Klebsiella pneumoniae.
Feng J; Gao L; Li L; Zhang Z; Wu C; Li F; Tong Y
Virus Res; 2021 Oct; 303():198506. PubMed ID: 34271040
[TBL] [Abstract][Full Text] [Related]
28. Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance.
Lourenço M; Osbelt L; Passet V; Gravey F; Megrian D; Strowig T; Rodrigues C; Brisse S
Microbiol Spectr; 2023 Aug; 11(4):e0481222. PubMed ID: 37338376
[TBL] [Abstract][Full Text] [Related]
29. Novel lytic bacteriophages of Klebsiella oxytoca ABG-IAUF-1 as the potential agents for mastitis phage therapy.
Amiri Fahliyani S; Beheshti-Maal K; Ghandehari F
FEMS Microbiol Lett; 2018 Oct; 365(20):. PubMed ID: 30212876
[TBL] [Abstract][Full Text] [Related]
30. Functional and comparative genome analysis of novel virulent actinophages belonging to Streptomyces flavovirens.
Sharaf A; Mercati F; Elmaghraby I; Elbaz RM; Marei EM
BMC Microbiol; 2017 Mar; 17(1):51. PubMed ID: 28257628
[TBL] [Abstract][Full Text] [Related]
31. Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of
Bleriot I; Trastoy R; Blasco L; Fernández-Cuenca F; Ambroa A; Fernández-García L; Pacios O; Perez-Nadales E; Torre-Cisneros J; Oteo-Iglesias J; Navarro F; Miró E; Pascual A; Bou G; Martínez-Martínez L; Tomas M
Microb Genom; 2020 May; 6(5):. PubMed ID: 32375972
[No Abstract] [Full Text] [Related]
32. Complete nucleotide sequence of Klebsiella phage P13 and prediction of an EPS depolymerase gene.
Shang A; Liu Y; Wang J; Mo Z; Li G; Mou H
Virus Genes; 2015 Feb; 50(1):118-28. PubMed ID: 25392088
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Novel
Mulani MS; Kumkar SN; Pardesi KR
Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
[TBL] [Abstract][Full Text] [Related]
34. Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101.
Ciacci N; D'Andrea MM; Marmo P; Demattè E; Amisano F; Di Pilato V; Fraziano M; Lupetti P; Rossolini GM; Thaller MC
Viruses; 2018 Sep; 10(9):. PubMed ID: 30205588
[TBL] [Abstract][Full Text] [Related]
35. Characterization of extended-spectrum-β-lactamase producing Klebsiella pneumoniae phage KP1801 and evaluation of therapeutic efficacy in vitro and in vivo.
Wintachai P; Naknaen A; Thammaphet J; Pomwised R; Phaonakrop N; Roytrakul S; Smith DR
Sci Rep; 2020 Jul; 10(1):11803. PubMed ID: 32678251
[TBL] [Abstract][Full Text] [Related]
36. Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.
Jonas D; Spitzmüller B; Daschner FD; Verhoef J; Brisse S
Res Microbiol; 2004; 155(1):17-23. PubMed ID: 14759704
[TBL] [Abstract][Full Text] [Related]
37. Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant
Bai J; Zhang F; Liang S; Chen Q; Wang W; Wang Y; Martín-Rodríguez AJ; Sjöling Å; Hu R; Zhou Y
Front Cell Infect Microbiol; 2022; 12():897531. PubMed ID: 35865823
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic and Genomic Comparison of
Pacios O; Fernández-García L; Bleriot I; Blasco L; Ambroa A; López M; Ortiz-Cartagena C; Cuenca FF; Oteo-Iglesias J; Pascual Á; Martínez-Martínez L; Domingo-Calap P; Tomás M
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062209
[No Abstract] [Full Text] [Related]
39. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
[TBL] [Abstract][Full Text] [Related]
40. Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect.
Li M; Li P; Chen L; Guo G; Xiao Y; Chen L; Du H; Zhang W
Virus Genes; 2021 Oct; 57(5):434-442. PubMed ID: 34156584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
